Project Details
| Status | Active |
|---|---|
| Effective start/end date | 3/1/19 → 2/28/25 |
A Phase III Randomized, Placebo-Controlled Study of Pembrolizumab (MK-3475, NSC #776864)) in addition to Paclitaxel and Carboplatin for Measurable Stage III or IVA, Stage IVB or Recurrent Endometrial Cancer
- Kamat, Aparna A. (PI)
- Darcourt, Jorge (CoI)
- Singh, Monisha (CoI)
- Suri, Anuj (CoI)
- Zaid, Tarrik (CoI)
Project: Non Profit